Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Other |
Loved one's perspective of deprescribing |
Perspectives from focus groups |
6 months |
|
Primary |
Successful Discontinuation (Difference in mean number of medications; reduction in dose) |
Difference in mean number of medications; number of medications reduced in dose |
6 months |
|
Secondary |
Difference in level of cognition |
The Mini Mental Status Examination |
Baseline, 6 months |
|
Secondary |
Difference in level of quality of life |
EuroQol five dimensions questionnaire (EQ5D-5L) will measure quality of life. Scores range from 0 (low quality of life) to 1 (high quality of life). |
Baseline, 6 months |
|
Secondary |
Difference in number of falls |
Total number of falls resulting in medication consultation or treatment recorded in hospital admission and primary care records, and by patient |
Baseline, 6 months |
|
Secondary |
Difference in level of sleep |
The sleep question on the 15-Dimensional (15-D) scale will be used. Scores range from 1 (no sleep problems) to 5 (severe sleep problems). |
Baseline, 6 months |
|
Secondary |
Changes in medication side effects and symptoms (adverse) |
Patient self-report of appearance (new or worsening) of side effects associated with medications |
1-week, 3 months, 6 months |
|
Secondary |
Changes in medication side effects and symptoms (positive) |
Patient self-report of disappearance (improvement or disappearance) of side effects associated with medications |
1-week, 3 months, 6 months |
|
Secondary |
Difference in number of serious adverse events |
Any event that requires in-patient hospitalization or prolongation of existing hospitalization, causes congenital malformation, results in persistent or significant disability or incapacity, is life-threatening or results in death (Health Canada (2011) Guidance Document for Industry - Reporting Adverse Reactions to Marketed Health Products) |
1-week, 3 months, 6 months |
|
Secondary |
Difference in level of physical functioning capacity and ability |
Time on the timed-up-and-go test |
Baseline, 6 months |
|
Secondary |
Difference in level of performance of activities of daily living |
Barthel Index will be used to measure performance of activities of daily living. Ten activities are scored in terms of level of independence or assistance, with higher scores reflecting higher level of independent performance. |
Baseline, 6 months |
|
Secondary |
Difference in level of frailty |
The total score on the Edmonton Frail Scale will be used to measure frailty. The scale included 11 items, with scores ranging from 0 (not frail) to 17 (severe frailty). |
Baseline, 6 months |
|
Secondary |
Difference in level of healthcare utilization use (hospitalizations) |
Number of hospitalizations |
Baseline, 6 months |
|
Secondary |
Difference in level of healthcare utilization use (emergency department visits) |
Number of emergency department visits |
Baseline, 6 months |
|
Secondary |
Difference in level of healthcare utilization use (physician visits) |
Number of physician visits |
Baseline, 6 months |
|
Secondary |
Enrollment rate |
Number of participants that enroll in study relative to number of participant invited to participant |
6 months |
|
Secondary |
Completion rate |
Number of participants that complete 6-month collection relative to number of participants enrolled |
6 months |
|
Secondary |
Time to complete measures |
Average duration of data collection appointments |
Baseline, 6 months |
|
Secondary |
Difference in level of mood |
The total score on the Geriatric Depression Scale (Short Form) will be used to measure mood. The scale includes 15 yes/no items and score range from 0 to 15, with high scores indicating depression. |
Baseline, 6 months |
|
Secondary |
Difference in level of concern over falling |
The score on the Falls Efficacy Scale-International (Short Version) will be used to measure falling-related concerns. The scale includes 7 items, with scores ranging from 7 (no concern) to 28 (severe concern of falling) |
Baseline, 6 months |
|
Secondary |
Difference in level of pain |
The Brief Pain Inventory (short form) will be used to measure pain severity (mean of 4 items, rated 0-10) and pain interference (mean of 7 items, rated 0-10). Higher scores represent higher pain severity and interference. |
Baseline, 6 months |
|
Secondary |
Difference in level of incontinence |
Frequency of incontinence as recorded in patient electronic medical record |
Baseline, 6 months |
|